Search

Search Constraints

You searched for: Author/Creator Forget, Marie-Andrée

Search Results

1. Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes. Issue 2 (2nd February 2022)

2. CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signaling. Issue 7 (26th July 2022)

3. Development of novel combinations of targeted and immunotherapies by understanding immune resistance using a high throughput assay of T cell mediated cytotoxicity. (7th November 2013)

4. Effect of neoadjuvant chemotherapy on the immune microenvironment in non–small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches. Issue 1 (6th June 2018)

5. Genetically modified artificial antigen-presenting cells (aAPC) for expansion of melanoma tumor infiltrating lymphocytes with optimal properties for adoptive cell therapy. (7th November 2013)

6. Molecular and immune heterogeneity in synchronous melanoma metastases. (4th November 2015)

7. Molecular and immune heterogeneity in synchronous melanoma metastases. Issue 2 (December 2015)

8. Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set. Issue 1 (December 2016)

9. Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study. (3rd June 2017)

10. Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma. Issue 5 (21st May 2021)